These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Pincus T; Bergman MJ; Yazici Y Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic. Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866 [TBL] [Abstract][Full Text] [Related]
10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio. Lanse SB; Arnold GL; Gowans JD; Kaplan MM Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557 [TBL] [Abstract][Full Text] [Related]
11. [Methotrexate. Pharmacology applied to the treatment of rheumatoid arthritis]. Chassagne P; Levesque H; Moore N Therapie; 1990; 45(6):499-504. PubMed ID: 2080488 [TBL] [Abstract][Full Text] [Related]
12. Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis. Ward JR J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():3-6. PubMed ID: 3913774 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate: a perspective of its use in the treatment of rheumatic diseases. Willkens RF; Watson MA J Lab Clin Med; 1982 Sep; 100(3):314-21. PubMed ID: 7108346 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms. Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153 [TBL] [Abstract][Full Text] [Related]
16. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW; Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128 [TBL] [Abstract][Full Text] [Related]
17. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784 [TBL] [Abstract][Full Text] [Related]
18. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758 [TBL] [Abstract][Full Text] [Related]
19. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. Gilani ST; Khan DA; Khan FA; Ahmed M J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647 [TBL] [Abstract][Full Text] [Related]
20. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis. Willkens RF J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():21-4. PubMed ID: 3913772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]